InDex Pharmaceuticals Holding AB (FLERIE) Income Statement

Last quarter (Q4 2025), InDex Pharmaceuticals Holding AB's total revenue was kr2.50M, an increase of Infinity% from the same quarter last year. In Q4, InDex Pharmaceuticals Holding AB's net income was kr-541.00M. See InDex Pharmaceuticals Holding AB’s key income statements, including revenue, expenses, profit, and income.